Open AccessFeatures of tuberculosis diagnosis in the COVID-19
Author(s) -
O. L. Ekaterincheva,
Анна Малкова,
В. Е. Карев,
I. V. Kudryavtsev,
Ulia Zinchenko,
Татьяна Борисовна Потепун,
Д. А. Кудлай,
Анна Старшинова
Publication year - 2021
Publication title -
žurnal infektologii
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.185
H-Index - 5
eISSN - 2499-9865
pISSN - 2072-6732
DOI - 10.22625/2072-6732-2021-13-1-117-123
Subject(s) - tuberculosis , medicine , pandemic , concomitant , covid-19 , epidemiology , incidence (geometry) , infectious disease (medical specialty) , disease , intensive care medicine , pediatrics , pathology , physics , optics
2020 began with the most significant pandemic COVID-19 in the history of this century. The epidemiology indicators are growing every day. The spread of COVID-19 may affect an increase in the incidence of tuberculosis, despite a decrease in the incidence rate that is associated with objective difficulties in detecting tuberculosis against the background of COVID-19 and severe complications after the new coronavirus infection. Tuberculosis is one of the infectious diseases, and the problem of its spread continues to be relevant throughout the World. The effect of the SARS-CoV-2 virus can cause certain difficulties in the diagnosis and treatment of tuberculosis infection. The possibility of concomitant these infectious diseases can affect the clinical course of tuberculosis, an influence on mortality of the disease, but at the same time, there is a decrease in the number of cases that is not objective. The authors analyzed the currently published data on detecting tuberculosis in the conditions of the COVID-19 problem and presented difficulties in the diagnosis of COVID-19 and TB concomitant diseases with a description in the clinical case.